about
Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 proteinEBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cellsEpstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a proteinT cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesEbola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cellsSymbionts as major modulators of insect health: lactic acid bacteria and honeybeesImproved in vitro culture of Plasmodium falciparum permits establishment of clinical isolates with preserved multiplication, invasion and rosetting phenotypesHHV-8 encoded LANA-1 alters the higher organization of the cell nucleus.PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.Extended Field Laser Confocal Microscopy (EFLCM): combining automated Gigapixel image capture with in silico virtual microscopyNK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab.Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma.Filamin B deficiency in mice results in skeletal malformations and impaired microvascular developmentControl of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan.EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexesA prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myelomaHigh-throughput mammographic-density measurement: a tool for risk prediction of breast cancerConfrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth.Molecular typing of human herpesvirus 8 isolates from patients with Kaposi's sarcoma in Hungary.Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs.Novel signatures of cancer-associated fibroblasts.The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth.Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin.Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.Sensitivity of chronic lymphocytic leukemia cells to small targeted therapeutic molecules: An in vitro comparative study.p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domainImproved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes.EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain.Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line.Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion.RB-reconstituted human retinoblastoma cells form RB-positive intraocular and intracerebral but not subcutaneous tumors in SCID mice.
P50
Q24293065-70D49B7A-9C0C-4432-A4FC-CB2561CA7F8DQ24301652-9BD2F30D-0399-4E52-B939-4C23D75ECBB8Q24317671-FBC1D524-1342-4046-84B7-D1AF0209CFCEQ24681203-4E82E224-36B7-471E-85B5-0FBA8A52D6FDQ24794365-B1E7D958-D95F-4224-9348-05BD2C2173D5Q27307129-D6215A3A-9B6F-438C-AA80-D1CAED874171Q27310757-9984C875-E536-4432-B0F7-1613BB4642F4Q30479353-E1A87223-90F0-4D3F-9355-EF3D4667CEA6Q30486972-A3260B2B-77F3-46BD-909F-2E52248BF6C4Q30606334-09E5B82F-3F8C-455E-A861-003EA047AFF5Q33263443-8CEA4119-0707-41ED-9B10-DC17D628D445Q33297034-CEC44E8D-2C05-44BC-BF84-77F29EFA647FQ33351812-C761A78F-FADB-4637-AA80-677FD9BE5055Q33373860-574B12D9-521A-4A6A-8048-4E923A56484BQ34047294-EAA04683-C252-4CD5-98C3-B467D6EE376DQ34472588-D6F0B2B7-1059-4998-B007-B87A9499A176Q35275675-017057EE-21AA-4821-9D90-E96C8247F453Q35591895-B48CBA5C-00B7-412F-8BBF-ADD11BFBE6C5Q35676707-32928DDA-CFCF-4F9E-AA19-32A7F8F0A779Q36170766-2836972E-C44D-41C8-B21E-AC4636068B0FQ36535405-2708C1ED-F4B6-4712-851C-6C1954098D1AQ36622176-BC3E5E40-61DC-4EDC-894B-5407580513CEQ36924460-66B598ED-E684-4A22-83E9-2FC135A7485AQ38389103-B0C89086-5627-4A63-8229-0DDD40926855Q38392931-553ADEEE-03F8-4CB2-A2F2-A6CC07B5FA02Q38936708-7D1C2312-E7F2-47D6-ADFA-007B6B6BE1D2Q39210456-7B3346C9-271F-4122-B6C5-9E6F0DA815B4Q39384224-D2F070BB-6784-43CC-B9F8-196CFE38BEACQ39469430-6C48FDBB-BE94-4C12-84A4-FDDC9B30166EQ39756815-D4DB3A05-DFE5-486D-BBCB-231C57CC233FQ39950402-9D77C9A9-7F75-4A2A-A91E-882380E18FA6Q40006148-3C41D47B-4630-454E-BA4B-89D4D92C073CQ40309657-B265FC94-FAC3-419E-B26B-E10355D09DF8Q40392809-E8123AD4-94C4-4627-9985-B0D728C24C57Q40680357-ABC7FDEF-F583-417E-9202-94AEC586314FQ40789575-AF65EA2F-D270-4738-BA4F-9B96EBAB908BQ41113668-6340500C-F606-44A0-86F2-2FE3F3A11689Q41144906-5FB3CFA0-FF8E-4CD8-B201-AF9DC8B91014Q41289327-38B22ABE-348A-4584-846A-4F41A338A4A9Q41343456-F5079493-E349-4C4B-BD92-6A538BE1144C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laszlo Szekely
@ast
Laszlo Szekely
@en
Laszlo Szekely
@es
Laszlo Szekely
@nl
type
label
Laszlo Szekely
@ast
Laszlo Szekely
@en
Laszlo Szekely
@es
Laszlo Szekely
@nl
prefLabel
Laszlo Szekely
@ast
Laszlo Szekely
@en
Laszlo Szekely
@es
Laszlo Szekely
@nl
P106
P31
P496
0000-0001-6144-6573